"Potential drug treatments are tested on paper, in laboratories and eventually in thousands of people. But every drug that goes through this cycle â€“ every drug that FDA approves â€“ carries some risk. One of the first lines of defense against "...
TRANSDERM SCOP® (Novartis Consumer)
(transdermal scopolamine) 1.5 mg
Transdermal Therapeutic System
Programmed to deliver in-vivo approximately 1.0 mg of scopolamine over 3 days
The Transderm Scop (transdermal scopolamine) system is a circular flat patch designed for continuous release of scopolamine following application to an area of intact skin on the head, behind the ear. Each system contains 1.5 mg of scopolamine base. Scopolamine is (alpha)-(hydroxymethyl) benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo [184.108.40.206 2,4 ] non-7-yl ester. The empirical formula is C 17 H 21 NO 4. and its structural formula is:
Scopolamine is a viscous liquid that has a molecular weight of 303.35 and a pKa of 7.55-7.81. The Transderm Scop (scopolamine) system is a film 0.2 mm thick and 2.5 cm 2 , with four layers. Proceeding from the visible surface towards the surface attached to the skin, these layers are: (1) a backing layer of tan-colored, aluminized, polyester film; (2) a drug reservoir of scopolamine, light mineral oil, and polyisobutylene; (3) a microporous polypropylene membrane that controls the rate of delivery of scopolamine from the system to the skin surface; and (4) an adhesive formulation of mineral oil, polyisobutylene, and scopolamine. A protective peel strip of siliconized polyester, which covers the adhesive layer, is removed before the system is used. The inactive components, light mineral oil (12.4 mg) and polyisobutylene (11.4 mg), are not released from the system.
What are the possible side effects of scopolamine transdermal (Transderm-Scop)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Remove the scopolamine transdermal patch and call your doctor at once if you have any of these serious side effects:
- eye pain or redness, seeing halos around lights;
- blurred vision and increased sensitivity to light;
- confusion, agitation, extreme fear, hallucinations, unusual thoughts or behavior; or
- urinating less than usual or not at all.
What are the precautions when taking scopolamine (Transderm Scop)?
Before using scopolamine, tell your doctor or pharmacist if you are allergic to it; or to other belladonna alkaloids (e.g., atropine); or if you have any other allergies. This product may contain inactive ingredients (such as adhesives), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: a certain type of glaucoma (narrow-angle).
Before using this medication, tell your doctor or pharmacist your medical history, especially of: a certain type of glaucoma (wide-angle), seizures, mental/mood disorders (e.g., psychosis, anxiety), uncontrolled pain, breathing problems (e.g., asthma,...
Last reviewed on RxList: 8/1/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Transderm Scop Information
Transderm Scop - User Reviews
Transderm Scop User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.